Sangamo Therapeutics
SGMO
$0.49
Share price
-5.99%
Change (1 day)
-72.12%
Change (1 year)
EPS for Sangamo Therapeutics (SGMO)
EPS in 2023 (TTM): -$1.44
According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.44. In 2022 the company made an earnings per share (EPS) of -$1.25 a decrease over its 2021 EPS that were of -$1.24.
EPS history for Sangamo Therapeutics from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.44 | 15.2% |
| 2022 | -$1.25 | 0.81% |
| 2021 | -$1.24 | 33.33% |
| 2020 | -$0.93 | 6.9% |
| 2019 | -$0.87 | 22.54% |
| 2018 | -$0.71 | 1.43% |
| 2017 | -$0.70 | -31.37% |
| 2016 | -$1.02 | 75.86% |
| 2015 | -$0.58 | 48.72% |
| 2014 | -$0.39 | -17.02% |
| 2013 | -$0.47 | 9.3% |
| 2012 | -$0.43 | -39.44% |
| 2011 | -$0.71 | 29.09% |
| 2010 | -$0.55 | 22.22% |
| 2009 | -$0.45 | -25% |
| 2008 | -$0.60 | 3.45% |
| 2007 | -$0.58 | 5.45% |
| 2006 | -$0.55 | 10% |
| 2005 | -$0.50 | -9.09% |
| 2004 | -$0.55 | 30.95% |
| 2003 | -$0.42 | -65.29% |
| 2002 | -$1.21 | 15.24% |
| 2001 | -$1.05 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -1,078.15% | 🇺🇸 USA |
 Amgen AMGN | $14.15 | -1,082.64% | 🇺🇸 USA |
 Biogen BIIB | $18.46 | -1,381.94% | 🇺🇸 USA |
 Dow DOW | $1.84 | -227.78% | 🇺🇸 USA |
 Gilead Sciences GILD | $4.39 | -404.86% | 🇺🇸 USA |
 Merck MRK | $1.82 | -226.51% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$4.11 | 185.42% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.78 | -154.07% | 🇺🇸 USA |